Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: Suggestive possible therapeutic targets

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages 103-108

  Seif El Nasr, H ^a   Shaker, O G ^a   Fawzi, M M T ^a   El Hanafi, G ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPIGMENTATION; HYPOPIGMENTED MYCOSIS FUNGOIDES; HYPOPIGMENTED TINEA VERSICOLOR; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; QUANTITATIVE ASSAY; SCHOOL CHILD; SKIN BIOPSY; SKIN DEFECT; TINEA VERSICOLOR; VITILIGO;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MYCOSIS FUNGOIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; SKIN NEOPLASMS; TINEA VERSICOLOR; TUMOR NECROSIS FACTOR-ALPHA; VITILIGO;

EID: 84872850190     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04368.x     Document Type: Article

References (32)

1. Jimbo K, Quevedo WC Jr, Prota G, Fitzpatrick TB,. Biology of melanocytes. In, Freedberg IM, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine, 5th edn. McGraw-Hill, USA, 1999, 15: 192.
2. Gordon PR, Mansur CP, Gilchrest BA,. Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol 1989; 92: 565-572.
3. Kondo S,. The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA irradiation. J Invest Dermatol 1999; 4: 177-183.
4. Hautmann G, Moretti M, Lotti T,. Pathogenesis of vitiligo: Evidence for a possible ongoing disorder of the cutaneous microenvironment. In, Lotti T, Hercogova J, eds. Vitiligo: Problems and solutions, 1st edn. Informa Health Care, 2004, 9: 106.
5. Imokawa G, Yada Y, Kimura M, Morisaki N,. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem J 1996; 313: 625-631.
6. Imokawa G, Yada Y, Miyagishi M,. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992; 267: 24675-24680.
7. Imokawa G, Kobayashi T, Miyagishi M, et al. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis. Pigment Cell Res 1997; 10: 218-228.
8. Swope VB, Abdel-Malik Z, Kassem LM, et al. Interleukins 1α and 6, tumour necrosis factor alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J invest Dermatol 1991; 96: 180-185.
9. Martinez-Esparza M, Jimenez-Cervantes C, Beermann F, et al. TGF-β inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and TRP-1. J Biol Chem 1997; 272: 3967-3972.
10. Ozdemir M, Yiller G, Wolf R, et al. Increased basic fibroblast growth factor levels in serum and blister fluid from patients with vitiligo. Acta Derm Venereol 2000; 80: 438-439.
11. Moretti S, Spallanzani A, Amato L, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002; 15: 87-92.
12. Bunn PA, Lamberg SI,. Report of the committee on Staging and Classification of Cutaneous T-cell Lymphoma. Cancer Treat Rep 1979; 63: 725-728.
13. Baumgartner AT, Strong CH, eds. Conducting and Reading Research in Health and Human Performance, 2nd edn. McGraw Hill, Europe, Middle east, Africa, 1998: 1-140.
14. Birol A, Kisa U, Kurtipek GS, et al. Increased tumour necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with non segmental vitiligo. Int J Dermatol 2006; 45: 992-993.
15. Bradford CS, Sun L, Barnes DW,. Basic Fibroblast growth factor stimulates proliferation and suppresses melanogenesis in cell cultures derived from early zebrafish embryos. Mol Mar Biol Biotechnol 1994; 3: 78-86.
16. Zhang XQ, Feng J, Mou KH, et al. Effects of bFGF and alpha-MSH on adhesion and migration of human melanocytes in vitro. Zhejiang Da Xue Xue Bao Yi Xue Ban 2006; 35: 161-164.
17. Wu CS, Lan CC, Chiou MH, Yu HS., Basic fibroblast growth factor promotes melanocyte migration via increased expression of p125 (FAK) on melanocytes. Acta Derm Venereol 2006; 86: 498-502.
18. Moretti S, Fabbri P, Baroni G, et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 2009; 24: 849-857.
19. Tensen CP, Vermeer MH, Vander-Stoop PM, et al. Epidermal interferon-gamma-inducible protein-10 (IP-10) and monkine induced by gamma-interferon but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphoma. J Invest Dermatol 1998; 111: 222-226.
20. Savvateeva MV, Savina MI, Markusheva LI, et al. Relative content of cytokines in different tissues in mycosis fungoides. Bull Exp Biol Med 2002; 134: 175-176.
21. Papadavid E, Economidou J, Psarra A, et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 2003; 148: 709-718.
22. El-Darouti MA, Marzouk SA, Azzam O, et al. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis). Eur J Dermatol 2006; 16: 17-22.
23. El shabrawi-Caelen L, Cerroni L, Medeiros LJ, et al. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 2002; 26: 450-457.
24. Ardigo M, Borroni G, Muscardin L, et al. Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases. J Am Acad Dermatol 2003; 49: 264-270.
25. La Duca JR, Gaspari AA,. Targeting human TNF-α. New drugs used to modulate inflammatory diseases. Dermatol Clin 2001; 19: 617-635.
26. Watanabe S, Kano R, Sato H, et al. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001; 116: 769-773.
27. Kano R,. Cytokine production and dermatophytosis. Nihon Ishinkin Gakkai Zasshi 2004; 45: 131-136.
28. Cui F, She XD, Li XF, Shen YN, Lu GX, Liu WD,. Effects of Malassezia isolates on cytokine production associated with melanogenesis by keratinocytes. Zhongguo Yi Xue Yuan Xue Bao 2007; 29: 196-200.
29. Lv Y, Li Q, Wang L, et al. Use of anti-tumor necrosis factor agents: a possible therapy for vitiligo. Med Hypotheses 2009; 72: 546-547.
30. Ramirez-Hernandez M, Marras C, Martinez-Escribano JA,. Infliximab-induced vitiligo. Dermatology 2005; 210: 79-80.
31. Campanati A, Giuliodori K, Ganzetti G, et al. A patient with psoriasis and vitiligo treated with etanercept. Am J Clin Dermatol 2010; 11: 46-48.
32. Kim NH, Torchia D, Rouhani P, et al. Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters. Cut Ocul Toxicol 2011; 30: 225-227.